Literature DB >> 2699936

Depression in schizophrenia: current guidelines to treatment.

S J Bartels1, R E Drake.   

Abstract

Depressive symptoms and syndromes in schizophrenia are common but heterogeneous with respect to etiology, presentation, course, and treatment. Based on a comprehensive differential diagnosis that identifies ten clinical subgroups, the authors review relevant treatment studies and offer current treatment guidelines. The clinical recommendations focus on addressing underlying problems such as medication side effects and substance abuse, attempting to identify and treat medication-responsive syndromes, and preventing suicide. The categories and treatments presented here are expected to evolve as researchers continue to elucidate clinically meaningful syndromes and to develop specific treatments. Nevertheless, current knowledge suggests that many schizophrenics with depression and depression-like symptoms can be treated effectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2699936     DOI: 10.1007/BF01064357

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  122 in total

1.  The long-term use of lithium in aggressive prisoners.

Authors:  J P Tupin; D B Smith; T L Clanon; L I Kim; A Nugent; A Groupe
Journal:  Compr Psychiatry       Date:  1973 Jul-Aug       Impact factor: 3.735

Review 2.  Who should receive clozapine?

Authors:  S R Marder; T Van Putten
Journal:  Arch Gen Psychiatry       Date:  1988-09

3.  Stages of schizophrenic decompensation and reintegration.

Authors:  P T Donlon; K H Blacker
Journal:  J Nerv Ment Dis       Date:  1973-09       Impact factor: 2.254

4.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

5.  Medical problems of chronic patients in a community support program.

Authors:  S Farmer
Journal:  Hosp Community Psychiatry       Date:  1987-07

6.  Treatment of schizoaffective disorders.

Authors:  P J Goodnick; H Y Meltzer
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

7.  Postpsychotic state, convalescent environment, and therapeutic relationship in schizophrenic outcome.

Authors:  L Kayton; J Beck; S D Koh
Journal:  Am J Psychiatry       Date:  1976-11       Impact factor: 18.112

Review 8.  Behavioral toxicity of antipsychotic drugs.

Authors:  T Van Putten; S R Marder
Journal:  J Clin Psychiatry       Date:  1987-09       Impact factor: 4.384

9.  Recent psychostimulant use in hospitalized schizophrenics.

Authors:  M L Richard; B I Liskow; P J Perry
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384

10.  Stages of onset of schizophrenic psychosis.

Authors:  J P Docherty; D P Van Kammen; S G Siris; S R Marder
Journal:  Am J Psychiatry       Date:  1978-04       Impact factor: 18.112

View more
  1 in total

Review 1.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk.

Authors:  Ye-Meng Mao; Ming-Dao Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.